Longitudinal analysis of circulating biomarkers to monitor advanced EGFR mutated (EGFR plus ) non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Ding, P. N. [1 ]
Becker, T. [1 ]
Bray, V. J. [2 ]
Chua, W. [2 ]
Ma, Y. F. [1 ]
Luk, A. [1 ]
Po, J. [1 ]
Lynch, D. [1 ]
Caixeiro, N. [1 ]
de Souza, P. [1 ]
Roberts, T. L. [1 ]
机构：
[1] Ingham Inst Appl Med Res, Translat Med Oncol Grp, Liverpool, Australia
[2] Liverpool Hosp, Dept Med Oncol, Liverpool, Australia
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1863P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Plasma metabolite biomarkers for EGFR-mutated non-small cell lung cancer (NSCLC)
    Thamlikitkul, Lucksamon
    Manocheewa, Siriphan
    Limjiasahapong, Suphitcha
    Wanichthanarak, Kwanjeera
    Panya, Atikorn
    Poungvarin, Naravat
    Pomyen, Yotsawat
    Khoomrung, Sakda
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [2] Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population
    Aguiar, Filipa
    Fernandes, Gabriela
    Queiroga, Henrique
    Machado, Jose Carlos
    Cirnes, Luis
    Moura, Conceicao Souto
    Hespanhol, Venceslau
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (01): : 10 - 17
  • [3] Miliary EGFR mutated non-small cell lung cancer
    Nguyen, Mike M.
    Moore, Melissa M.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2021, 214 (03) : 118 - 118
  • [4] Evaluation of Texture Analysis Parameters in EGFR Mutated or ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
    Bluthgen, Maria V.
    Caramella, Caroline
    Rosellini, Silvia
    Leduc, Charlotte
    Facchinetti, Francesco
    Haspinger, Eva
    Ferte, Charles
    Michiels, Stefan
    Soria, Jean C.
    Besse, Benjamin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S703 - S703
  • [5] Repeated biopsy for mutational analysis on EGFR-mutated non-small cell lung cancer (EGFR-NSCLC): Feasibility and safety
    Anguera, G.
    Riudavets, M.
    Torrego, A.
    Pajares, V.
    Gimenez, A.
    Lopez-Vilaro, L.
    Martinez, E.
    Trujillo-Reyes, J. C.
    Lerma, E.
    Majem, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [6] A Delphi Consensus on TKI Sequencing in Treating Advanced EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Wehler, T.
    Hirsh, V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1043 - S1043
  • [7] Longitudinal AXL assessment of circulating tumor cells (CTCs) and its clinical implication in the patients with EGFR mutated non-small cell lung cancer (NSCLC).
    Choi, Mi Young
    Moon, Da Hye
    Lee, Hae Ung
    Jo, Jong Min
    Sohn, Young Woong
    Jeon, Byung Hee
    Kim, Sang-We
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [8] EGFR Mutation in Non-Small Cell Lung Cancer is Influenced by EGFR Amplification and Biomarkers
    Pollen, M.
    Waterman, J. P.
    Ding, M.
    Alvarez, A.
    Boyd, M.
    Streifel, J.
    Noroberg, M. L.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 655 - 655
  • [9] The Management of Brain Metastases in Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer
    O'Rourke, Noelle
    Gray, Christine M. N.
    Coyte, Aishah
    Featherstone, Carolyn
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S526 - S526
  • [10] Progress in individualized treatment for EGFR-mutated advanced non-small cell lung cancer
    Inoue, Akira
    [J]. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2020, 96 (07): : 266 - 272
12345